Michael George Haydin

Equinox Ophthalmic, Inc. operates as a biotechnology company. It specializes in cataract, corneal and glaucoma surgery. The company was founded by John Berdahl and is headquartered in Sioux Falls, SD.

Visionary Ventures Management LLC (Visionary Ventures) is a venture capital firm founded in 2016 by Ehsan Sadri. The firm is headquartered in Aliso Viejo, California.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

IanTech, Inc. develops ophthalmic devices for cataract surgery. Its products include miLoop, miPhaco, miMissions, and miResources. The company was founded by Luke Clauson and Sean Ianchulev and is headquartered in Reno, NV.

CurvaFix, Inc. operates as an emerging medical device company. It develops novel solution for an unmet need in orthopedic trauma. The company is headquartered in Bellevue, WA.

Cagent Vascular LLC engages in manufacturing medical instruments. The company was founded by Carol Burns, Robert Giasolli and Peter Schneider and is headquartered in Wayne, PA.

Neuros Medical, Inc. develops neurostimulation therapies. It offers Altius System that consists of an implantable generator with an integrated rechargeable battery, cuff electrode, and external devices. The company was founded by Jon J. Snyder, Kevin L. Kilgore, and Niloy Bhadra in 2008 and is headquartered in Willoughby Hills, OH.

HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France.

Sectoral Asset Management Inc (Private Equity) (Sectoral Asset Management) is a private equity subsidiary of Sectoral Asset Management, Inc. founded in 2008 by Michael Sjöström. The firm is headquartered in Montréal, Quebec.

Part of Medtronic Plc, Medtronic Canada ULC is a leading Canadian healthcare technology company that aims to alleviate pain, restore health, and extend life by providing innovative technologies and therapies. With a team of over 90,000 passionate people, they address 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Medtronic Canada ULC has been proudly serving Canadian healthcare for over 50 years and is headquartered in Brampton, Ontario, with regional offices in Vancouver. The company's mission is to transform the lives of two people every second, every hour, every day, by engineering the extraordinary.

Transcend Medical, Inc. operates as a medical device company. It develops medical devices for the treatment of glaucoma, the cause of adult irreversible blindness. The company was founded in 2005 and is headquartered in Lake Forest, CA.

Sectoral Asset Management, Inc. (Sectoral) is an investment management firm headquartered in Montréal, Canada. The firm was founded in 2000 by Jérôme G. Pfund and Michael J. Sjöström. They are a wholly-owned subsidiary of Sectoral Asset Management Holding Ltd. in Hong Kong. Sectoral manages public and private equity healthcare strategies for investors around the world. Their clients include sovereign wealth funds, private banks, and family offices. In addition, they have long-standing sub-advisory relationships with institutional investors in Europe and Asia.

Flying L Management LLC (Flying L Management) is a venture capital firm founded in 2016. The firm is headquartered in Newport beach, California.

ReVision Optics, Inc. develops optical solutions for the treatment of presbyopia. The company also develops Raindrop Near Vision Corneal Inlay, which is a refractive surgery solution. ReVision Optics was founded by Hansen A. Yuan, Adrian Koppes and Alok Nigam in 1996 and is headquartered Lake Forest, CA.

BELKIN Vision Ltd. provides glaucoma laser treatment. The company was founded by Michael Belkin in 2013 and is headquartered in Tel Aviv, Israel.

Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN.

Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA.

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Neurolens, Inc. is a company that commercializes breakthrough technology to improve vision care. The company's patented contoured prism technology provides visual comfort for the nearly 65% of US adults who complain of headaches, neck/shoulder pain, and eyestrain when using digital devices, reading, or doing detail work. The company is based in Coppell, TX. Inspired by a breakthrough discovery linking optometry and neurology, Neurolens is unlocking a new dimension of vision care. The Neurolens contoured prism design helps the eyes work together comfortably, bringing the eyes into alignment to relieve painful symptoms. The technology is only available to independent eye care providers. The company was founded in 2012 by Davis Corley, and Pierre Bertrand has been the CEO of the company since 2019.

Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida.

DBL Holdings LLC provides financial services. The private company is based in New York, NY. The company was founded by Ira Scott Greenspan.

TearClear Corp. operates as an early-stage medical science company. It develops a hydrogel filter to remove potentially harmful preservatives from multi dose topical ophthalmic products used to treat chronic diseases such as glaucoma, dry-eye and allergic conjunctivitis. The company was founded by Anuj Chauhan in 2015 and is headquartered in Copley, OH.

Orasis Pharmaceuticals Ltd. operates as a clinical stage pharmaceutical company. It develops eye drops for the treatment of presbyopia as an alternative to reading glasses. The company was founded in 2015 and is headquartered in Herzliya, Israel.

Assil Eye Institute, Inc. is a renowned ophthalmology center that provides cutting-edge treatments for vision correction, cataracts, and retinal conditions. The American company's team of internationally recognized ophthalmologists offers advanced LASIK surgery and other state-of-the-art procedures to improve patients' vision.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Inflection Point Capital Management, Inc. provides investment advisory services. The company was founded by Matthew John Kiernan in 2009 and is headquartered in Toronto, Canada.

SafeOp Surgical, Inc. operates as a medical device company. It offers portable neuro monitoring devices that enable the detection of nerve damage, such as positioning effect, an injury to peripheral nerves related to patient positioning during surgery or prolonged sedation. The company was founded in 2011 and is headquartered in Hunt Valley, MD.

Private Medical Equity Inc (Private Medical Equity) is a private equity and venture capital firm founded by Ian Ianchulev in 1900. The firm is headquartered in San Francisco, California.

AEYE Health LLC is a digital health company that provides fully autonomous, AI-based diagnostic screening solutions for retinal imaging with results. The company is based in New York, NY. The company aims to make diagnostic screening practical, accurate, and accessible. Its screening solution for diabetic retinopathy is FDA-cleared and designed to allow primary care providers to perform diabetic eye exams in their clinics instead of referring to specialists. AEYE Health enables point-of-care screening for diabetic retinopathy to ensure that patients with diabetes are regularly screened for diabetic retinopathy. The company's comprehensive screening utilizes AI technology to diagnose or predict the development of a broad range of diseases from retinal images. The team consists of machine learning experts and leaders in ophthalmology and innovation. The company was founded by Zack Dvey-Aharon, Danny Margalit. Zack Dvey-Aharon has been the CEO since incorporation.

AEye Technologies, Inc. engages in the development of vision hardware, software and algorithms that act as the eyes and visual cortex of autonomous vehicles. It specializes in computer vision, autonomous driving, robotic vision, autonomous vehicles, lidar, sensor fusion, and three dimensional mapping. The company was founded by Luis Dussan, Ranson Wuller, Barry Behnken, and Jordan Greene in 2013 and is headquartered in Dublin, CA.

Kurobe Pharmaceuticals, Inc. manufactures pharmaceuticals.

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.

Tear Film Innovations, Inc. engages in the research and development of products for the treatment of evaporative dry eye and related syndromes. It offers iLux system, a handheld treatment device which enables eye care professionals to identify and treat blocked meibomian glands. The company was founded by Kabir Gambhir and Brian Kelleher in 2014 and is headquartered in San Diergo, CA.